SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001319244-20-000051
Filing Date
2020-02-13
Accepted
2020-02-13 16:13:20
Documents
1
Group Members
ICS OPPORTUNITIES, LTD.INTEGRATED ASSETS II LLCINTEGRATED ASSETS, LTD.INTEGRATED CORE STRATEGIES (US) LLCISRAEL A. ENGLANDERMILLENNIUM GROUP MANAGEMENT LLCMILLENNIUM INTERNATIONAL MANAGEMENT LPMILLENNIUM MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 OXFD_SC13GA1.htm SC 13G/A 155343
  Complete submission text file 0001319244-20-000051.txt   157414
Mailing Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVENUE, 8TH FLOOR NEW YORK NY 10103
Business Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVENUE, 8TH FLOOR NEW YORK NY 10103 (212) 841-4100
INTEGRATED CORE STRATEGIES (US) LLC (Filed by) CIK: 0001319244 (see all company filings)

IRS No.: 202196675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Business Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ 44 01235 442780
Oxford Immunotec Global PLC (Subject) CIK: 0001586049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87926 | Film No.: 20610666
SIC: 2835 In Vitro & In Vivo Diagnostic Substances